Skip to content

Singing programs can help those with lung disease

By API User

Singing songs by the likes of Elvis and The Beatles can improve the quality of life of people with lung disease and help reduce their symptoms, new research has found. The randomised-controlled trial was led by Professor Natasha Smallwood from Monash University and Alfred Health. It is unpublished but expected to be accepted by a … Continued

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

By API User

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light and Dark Skin Tones and No Occult Hypoxemia IRVINE, Calif.–BUSINESS WIRE– Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study … Continued

Nutrition and Lifestyle Medicine Symposium, Adelaide–FREE Student Scholarships Available!

By API User

Doctors For Nutrition is proud to announce the highly anticipated Nutrition & Lifestyle Medicine Symposium 2025 (NLMS25), set to take place in Adelaide this year. This landmark event brings together leading medical experts, healthcare professionals, and the wider community to explore the transformative impact of nutrition and lifestyle medicine on population health and wellbeing.  Student … Continued

NeuroScientific Biopharmaceuticals (ASX:NSB) Gains TGA Approval for First Patients in Special Access Program for StemSmart(TM) Crohn’s Disease Therapy

By API User

7 October 2025 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced that the first three patients have been approved for treatment under the Therapeutic Goods Administration (TGA)’s Special Access Program to receive its patented stem cell therapy, StemSmart™, to treat fistulising Crohn’s disease.  The patients are now part of Cohort 1 for … Continued

Health story: Don’t forget about your dogs this World Arthritis Day

By API User

Photo and filming opportunities with vets, families and their dogs   While human health usually dominates the spotlight on health awareness days, the impact of chronic pain on our much-loved pets and their families often goes underestimated and invisible. World Arthritis Day is an opportunity to shine a light on the importance of pain management … Continued

Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study

By API User

Torqur AG Announced Full Phase 2 Results at EADV Congress 2025 BASEL, Switzerland–BUSINESS WIRE– Torqur AG, subsidiary of Swiss Rockets incubator and a clinical-stage company advancing targeted therapies in oncodermatology and oncology, announced the results of the full Phase 2 proof-of-concept study results of topical bimiralisib gel (2%) for the treatment of actinic keratosis (AK) … Continued